Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together
By Theresa Schliep · March 9, 2026, 6:52 PM EDT
Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the...
To view the full article, register now.